Turner Scientific has formed an exclusive partnership with Sinclair Research, a
leading preclinical research provider.
Turner Scientific is very pleased to announce the formation of an exclusive partnership with one of the industry’s leading preclinical research providers, Sinclair Research. Based in Auxvasse, MO (close to our facility in Jacksonville, IL), Sinclair offers a variety of specialty biomedical research services at their 300,000 square foot, AAALAC accredited research and production facility. Sinclair also operates a Yucatan Miniature Swine facility in Maine.
While Sinclair has preclinical research expertise in many therapeutic areas such as metabolic disease, diabetes, inflammation, dermal disease, wound healing, orthopedic conditions, and ocular disease, they do not currently offer otic testing. Turner Scientific will therefore serve as Sinclair’s niche expert in auditory studies, offering Sinclair’s sponsors the ability to evaluate their compounds for efficacy in improving hearing and tinnitus, and potential for ototoxicity. Turner Scientific will also be able to offer its sponsors the capability of performing GLP-level otic research in Sinclair’s state-of-the-art GLP accredited facility. Additionally, Turner Scientific
sponsors will have access to multiple large animal models supported by Sinclair, including miniature swine, a species with which Sinclair has particular expertise.
Through this exclusive collaboration, Turner Scientific and Sinclair Research will add great value to the drug development programs of our sponsors. By combining our experience in auditory science, GLP studies, and multiple animal models, we hope to rapidly advance the field of otic research, and ultimately develop new treatments for hearing loss, tinnitus, and vestibular dysfunction which will benefit patients with few current options.